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Cancers create a systemic environment that 
predisposes neutrophils to release extracel-
lular DNA traps (NETs).1 We identified 
these traps as new players in cancer-asso-
ciated thrombosis. Furthermore, their 
characteristics may provide NETs with a 
high potential to modulate various facets 
of tumor biology including metastasis.
It is well known that tumor cells release 
cytokines in the bloodstream. Granulocyte 
colony-stimulating factor (G-CSF) is pro-
duced by many tumors and is found in 
the circulation of cancer patients. G-CSF 
increases the number of neutrophils and 
induces their activation. Neutrophilia is a 
frequent finding in cancer patients and is 
associated with a poor prognosis.
NETs were first identified as a host 
defense mechanism against pathogens.2 
Neutrophils engulf pathogens upon con-
tact but—after a strong stimulation, such 
as during sepsis—the entrapment and 
killing is mainly mediated through the 
release of NETs. Following activation by 
bacteria or cytokines, histone H3 becomes 
hypercitrullinated and the neutrophil 
nucleus undergoes a process of chromatin 
decondensation that leads to NETosis.3 
The released DNA is thus associated with 
citrullinated histone H3 (H3Cit) but also 
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with enzymes such as myeloperoxidase, 
cathepsin G and elastase. Our group 
recently showed that neutrophils, through 
the generation of NETs, provide a scaffold 
and a stimulus for platelet adhesion and 
thrombus formation.4 NETs were shown 
to promote coagulation as well.4,5 Since an 
increased risk of thrombosis is associated 
with cancer, we hypothesized that tumor-
induced neutrophils might have a role in 
cancer-associated thrombosis.
In a mammary cancer model, we 
observed neutrophilia that paralleled 
tumor growth. At the late stage of the dis-
ease, when high levels of DNA and H3Cit 
were found in the plasma, spontaneous 
thrombosis was observed in the lungs of 
tumor-bearing mice.1 This suggests that, 
as the disease progresses, NETs are spon-
taneously formed in the blood and their 
presence correlates with signs of thrombo-
sis. Are neutrophils from tumor-bearing 
mice more prone to NETs formation? 
Indeed, the stimulation of neutrophils iso-
lated from mice with chronic myelogenous 
leukemia or mice bearing solid mammary 
or lung carcinomas resulted in a high 
frequency of NET formation (Fig. 1A). 
Moreover, the simulation of a minor 
infection in mammary carcinoma-bearing 
mice at an early stage of the disease (with 
a low-dose of lipopolysaccharide) induced 
both NETosis and a pro-thrombotic state, 
as reflected by a DNA-dependent reduc-
tion in bleeding time. This suggested that 
both leukemia and solid tumors produce 
a factor that primes neutrophils to NET 
formation and predisposes the host to 
thrombosis. Since G-CSF induces neu-
trophilia and neutrophil activation and 
is produced by many tumors, we hypoth-
esized that G-CSF could be such a prim-
ing factor. High levels of G-CSF were 
found in the plasma of tumor-bearing 
mice. Moreover, we showed that G-CSF 
treatment of cancer-free mice leads to 
the hypercitrullination of histone H3 in 
neutrophils and hence predisposes them 
to NETosis. Thus, similar to the mam-
mary carcinoma model, the simulation of 
a minor infection in G-CSF-treated mice 
leads to NET release, shortened bleeding 
time and microthrombi formation in the 
lungs and kidneys.1 Our study identified 
extracellular chromatin released through 
NET generation as a key player in cancer-
associated thrombosis and unveiled new 
potential targets in the effort to minimize 
the incidence of thrombotic events in can-
cer patients.
Cancers prime neutrophils to release extracellular DNA traps through the systemic release of granulocyte colony-
stimulating factor (G-CsF). we recently showed that these circulating neutrophil extracellular traps (Nets) promote the 
establishment of a pro-thrombotic state. the role of Nets in cancer biology and tumor progression may prove much 
more than an unfortunate side effect of cancer.e22946-2  OncoImmunology  Volume 2 Issue 2
and the binding of adhesion molecules 
such as fibronectin,4 NETs may gener-
ate a seeding soil and promote tumor cell 
migration. Finally, NETs could also cover 
circulating cancer cells with platelets and 
enhance immune escape.
The finding that tumor-induced neu-
trophils are more prone to NET formation 
than their normal counterparts opens up a 
brand new area of research in cancer biol-
ogy. The understanding of the function 
of NETs in tumor progression may lead 
to new therapies preventing or inducing 
NETs formation by targeting the innate 
components of the host immune system. 
In addition, the neutralization of NETs in 
cancer patients would presumably reduce 
the mortality and morbidity resulting 
from cancer-induced thrombosis.
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of tumor progression (Fig. 1B). On one 
hand, NETs are procoagulant and the 
thrombin generated as a consequence 
of NETosis can affect all aspects of can-
cer.7 On the other hand, proteases are an 
integral part of NETs and may enhance 
tumor growth/invasion or, together with 
histones, mediate cytotoxic effects on the 
microenvironment.
The role of neutrophils in metastasis 
remains unclear but recent studies have 
shown that neutrophils directly interact 
with cancer cells and favor their migra-
tion.8 The presence of neutrophils was 
shown to establish a seeding bed for 
metastatic cancer cells.9 However, a toxic 
effect of tumor-activated neutrophils on 
cancer cells has also been described.10 All 
these phenomena may implicate NETs 
(Fig. 1B). In proximity of the vessel 
wall,4 NETs may favor the attachment of 
the cancer cell to the vessel and support 
extravasation. Through their proteases 
Aside from their implication in throm-
bosis, the formation of NETs in can-
cer may greatly affect tumor biology 
(Fig. 1B). Neutrophils have been observed 
in close association with cancer cells in 
vivo and within the tumor vasculature, 
but their exact role in tumor biology is still 
debated. Tumor-infiltrating neutrophils 
have been described to have pro- and anti-
tumoral potential. They also secrete cyto-
kines that initiate a positive feedback loop 
to recruit more neutrophils to the tumor. 
Intratumoral neutrophils affect the extra-
cellular matrix, promoting tumor growth 
and invasion, and support angiogenesis. 
Neutrophils have also been shown to be 
cytotoxic and induce the apoptotic demise 
of tumor cells. These opposing pheno-
types have been suggested to be related to 
neutrophil activation state.6 Since NETs 
are released in response to potent activa-
tion of neutrophils, it is conceivable that 
they could be implicated in different steps 
Figure 1. tumor-induced neutrophils are more sensitive to Net formation and Nets could be implicated in many steps of tumor progression. 
(A) representative photograph of a neutrophil in the process of releasing a neutrophil extracellular trap (Net). Immunostaining of neutrophils isolated 
from tumor-bearing mice following 1 h activation with calcium ionophore. significantly more Nets are produced by neutrophils from tumor-bearing 
mice than from tumor-free mice. scale bar = 5 μm. (B) Neutrophils are found in large quantities in the tumor where they can release Nets and affect 
growth and angiogenesis (1). the generation of Nets in the circulation could protect metastatic cells by adhering to them and recruiting platelets 
(2). Nets could also activate the endothelium and increase the rolling/adhesion of neutrophils (3) or adhere to the endothelium and favor the arrest 
of metastatic cells (4), hence allowing their transmigration to a distant organ such as the lung. Finally, the adhesion of a large quantity of Nets to the 
vasculature may initiate thrombosis by providing a scaffold for platelet adhesion, activation and thrombin generation (5).www.landesbioscience.com OncoImmunology  e22946-3
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